【摘 要】
：
Background and Purpose: In acute coronary syndrome (ACS), the most potential cause is thrombotic occlusion arising from ruptured vulnerable plaque based on coronary atherosclerosis, whereas coronary a
【机 构】
：
Department of Cardiology and Clinical Research Institute National Hospital Organization Kyushu Medic
【出 处】
：
BITs 2rd Annual World Cancer Congress of Cardiology-2010(201
论文部分内容阅读
Background and Purpose: In acute coronary syndrome (ACS), the most potential cause is thrombotic occlusion arising from ruptured vulnerable plaque based on coronary atherosclerosis, whereas coronary artery spasm (CAS) is another well-defined mechanism.We investigated clinical features of CAS in ACS in the real world.Methods: We retrospectively extracted consecutive suspected ACS patients in March 2006-July 2010 (n=720), based on symptoms and ischemic ECG changes and/or cardiac biomarkers.Among patients undergoing selective coronary angiography within two weeks after admission (n=655), patients with past CABG (n=20) were excluded, and the following two subgroups were finally selected; Organic (O): culprit lesion*3f75% organic stenosis with/without thrombotic occlusion, Spastic (S): either 1) organic stenosis<75% with positive acetylcholine test, or 2) organic stenosis<75% without acetylcholine test, but with transient ischemic ECG changes relieved by sublingual nitroglycerin.We compared clinical characteristics between the two groups.Results: The prevalence and in-hospital mortality of S were 59/635 (9.3%) and 0/59 (0%), and those of O were 516/635 (81.3%) and 17/516 (3.3%), respectively.In S, multivessel spasm was provoked in 31/42 patients (73.8%), myocardial infarction occurred in 11/59 patients (18.6%), and 2/59 patients (3.4%) experienced aborted sudden cardiac death.S was younger than O without significant sex distribution.The prevalence of hypertension, hypercholesterolemia, and diabetes mellitus were lower in S than in O, but that of smoking was not significantly different between the two groups (Table).Conclusions: CAS is one of the potential causes of ACS.Initial differential diagnosis is important in the treatment strategy of ACS.Smoking is a relatively potent risk factor in ACS caused by CAS than by significant organic stenosis.
其他文献
Blood pressure detection and control rates vary by country and jurisdiction.Typically, it is the primary care provider who is targeted to improve these variables, the implication being that somehow fa
Arterial hypertension continues to be the leading cause of morbiditiy and mortality in the world.The aim of antihypertensive treatment is to prevent adverse cardiovascular events.As the absolute benef
Drinking water is one of the essential daily activity that has been shown to have unexpected haemodynamie effects.Oral ingestion of water greatly elevates blood pressure in individuals with severe ort
Background: Women, especially those older than 65 years, wait longer than men before seeking treatment for Acute Coronary Syndrome.The most significant reasons for treatment delay in women are atypica
Acute coronary occlusion is the leading cause of death in the Westem World.There is an unmet need for the development of treatments to limit the extent of myocardial infarction (MI) during the acute p
Background There is less investigation on the impact of admission diabetic status (newly diagnosed, dietary control,oral medication, insulin injection) on survival among patients following an acute my
Autoimmunity is considered to play an important role in myocarditis, while also contributing to the progression to dilated cardiomyopathy and heart failure.The role ofT-helper (Th) cells is thought to
Highly sensitive troponin bioassays with lower limits of detection are enabling the early diagnosis of acute coronary syndromes (ACS).In patients presenting to emergency services with chest pain, the
Introduction The prevalence and potential for disease management of heart failure is unknown in most low and middle income countries (LMIC) such as Georgia, located in the Caucuses.We examined the fea
Gender and age differences in management of heart failure (HF) and quality of care have been well documented.The POWER Study is conducting a comprehensive assessment of gender equity for common chroni